Related Experiment Videos

Indications for daptomycin use in endocarditis and pacemaker lead infection and outcomes in Leeds, UK

Jonathan Sandoe1, Wazir Baig

  • 1Department of Microbiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK. jonathan.sandoe@leedsth.nhs.uk

Future Cardiology
|August 9, 2012
PubMed

Insights

Daptomycin shows limited efficacy for complex infective endocarditis, with only 53% cure rates in Staphylococcus cases. This highlights challenges in managing this serious heart valve infection.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Infective endocarditis is a complex infection, frequently caused by staphylococci.
  • Vancomycin, a traditional treatment, faces emerging resistance issues.
  • Daptomycin is approved for right-sided endocarditis, but data for other forms remain limited.

Purpose of the Study:

  • To evaluate the clinical outcomes of daptomycin treatment for infective endocarditis.
  • To assess daptomycin's efficacy and safety in a real-world clinical setting.

Main Methods:

  • Retrospective analysis of 19 patients treated with daptomycin (6 mg/kg) at the Leeds Endocarditis Service.
  • Data collected between January 2007 and December 2009.
  • Focus on staphylococcal infections and treatment duration (median 29 days).

Main Results:

  • The majority of cases involved Staphylococcus infections.
  • 53% of patients achieved a cure with daptomycin-containing regimens.
  • A significant mortality rate of 21% was observed during or within 30 days of treatment.

Conclusions:

  • Daptomycin demonstrates limited success in treating complex infective endocarditis, particularly staphylococcal cases.
  • Current management of infective endocarditis remains challenging.
  • Further research is needed to optimize treatment strategies for this severe condition.

Related Concept Videos

Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...